To determine whether the agonists of the JWA gene can selectively activate the expression of JWA in lung-cancer cells, two small-molecular compound agonists, JAC1 [30] and JAC4 [31] (Figure S2A), were used in experimental models. Here, ARL6IP5 is linked to lung cancer.